This innovative methodology supports the hypothesis that central insulin resistance could be developed by changes in insulin signaling similarly to the changes described in the periphery and at the same time provides a potential brain-specific insulin resistance biomarker to study brain atrophy with a non-invasive and relatively simple procedure. This evidence concerns the gene INS and Insulin resistance.